Topiramate: all 224 studies that test it
Page 2 of 3. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male SubjectsCompletedNCT04401137Phase 1
- Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine TreatmentStatus unknownNCT04154813Not applicable
- Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in AustraliaStatus unknownNCT03479086Phase 3
- Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With MigraineWithdrawnNCT03280342Phase 2
- Topiramate Augmenting Strategies for the Treatment of Alcohol Use DisorderCompletedNCT03120468Early Phase 1
- Improving Health Outcomes of Migraine Patients Who Present to the Emergency DepartmentWithdrawnNCT02945839Phase 4
- Physiologic Effects of Topiramate on CognitionCompletedNCT02884050Phase 1
- Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 WeeksTerminatedNCT02810483Phase 3
- Topiramate and Schizophrenia: Effects on Weight and PsychopathologyActive, not recruitingNCT02808533Not applicable
- Migraine Treatment in EDWithdrawnNCT02643719Not applicable
- Topiramate and Cerebrovascular Response in MigraineursCompletedNCT02424318Phase 4
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Topiramate and Severe ObesityCompletedNCT02273804Phase 3
- Topiramate-Phentermine Combinations for Cocaine DependenceCompletedNCT02239913Phase 1
- Topiramate Trial for Compulsive BuyingCompletedNCT02138058Phase 2
- Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese SubjectsTerminatedNCT02040311Phase 4
- Preventing Brain Injury in Infants With Congenital Heart DiseaseCompletedNCT01426542Phase 1
- The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced ObesityCompletedNCT01384279Not applicable
- Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With EpilepsyCompletedNCT01284530Phase 1/2
- Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?CompletedNCT01161017Not applicable
- Efficacy of Topiramate for Hospitalized Patients With AlcoholismCompletedNCT01145677Phase 2/3
- Topiramate for Hospitalized Patients With Alcoholism: a 12-week StudyStatus unknownNCT01135602Phase 4
- A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)CompletedNCT01114854Phase 1
- Topiramate Augmentation in Bulimia Nervosa Partial RespondersWithdrawnNCT00988481Phase 4
- A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective DisordersCompletedNCT00986336Phase 1
- A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder PatientsCompletedNCT00986128Phase 1
- Bioequivalence Study of Topiramate Tablets 25mg Under Fed ConditionsCompletedNCT00902473Not applicable
- Bioequivalence Study of Topiramate Tablets 25mg Under Fasting ConditionsCompletedNCT00901784Not applicable
- Medical Therapies for Chronic Post-Traumatic HeadachesTerminatedNCT00862095Phase 4
- Cognitive Side Effects of Commonly Prescribed Medications in Pediatric MigraineWithdrawnNCT00777218Not applicable
- Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary StudyCompletedNCT00769158Phase 1
- Topiramate for Binge Eating Disorder Among AdolescentsCompletedNCT00768677Not applicable
- A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic ImpairmentCompletedNCT00768209Phase 1
- Pharmacokinetics and Safety of Intravenous Topiramate in Adult PatientsCompletedNCT00753493Phase 1
- A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or SeparatelyCompletedNCT00752466Phase 1
- Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated DizzinessWithdrawnNCT00732108Not applicable
- Preventing Epilepsy After Traumatic Brain Injury With TopiramateTerminatedNCT00598923Early Phase 1
- The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress DisorderWithdrawnNCT00571246Phase 3
- Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese AdultsCompletedNCT00518466Phase 1
- Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol DependenceWithdrawnNCT00463775Phase 3
- Novel Pharmacotherapy for Dual DependenceStatus unknownNCT00448825Phase 3
- Detoxification and Treatment of Subjects With Medication Overuse HeadacheStatus unknownNCT00432549Phase 4
- The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence.SuspendedNCT00396734Not applicable
- Topiramate on Gambling-Related BehavioursWithdrawnNCT00370188Phase 2
- An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.CompletedNCT00307619Phase 3
- Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's DiseaseTerminatedNCT00296959Phase 2
- Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in ChildrenTerminatedNCT00286988Phase 4
- Safety and Efficacy Study of Topiramate to Aid in Smoking CessationCompletedNCT00280839Phase 3
- A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyCompletedNCT00266604Phase 4
- A Study of the Efficacy and Safety of Topiramate Treatment in Patients With EpilepsyCompletedNCT00266591Phase 3
- An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With TriptansCompletedNCT00261469Phase 2
- A Study of the Effectiveness and Safety of Topiramate for the Prevention of MigraineCompletedNCT00253175Phase 3
- Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1Status unknownNCT00249691Phase 3
- Efficacy of Topiramate for Weight Loss in Subjects With Metabolic SyndromeSuspendedNCT00243984Phase 3
- A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar DisorderCompletedNCT00240721Phase 3
- A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in ChildrenCompletedNCT00237302Phase 3
- Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient SettingCompletedNCT00237289Phase 3
- Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsCompletedNCT00236886Phase 3
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236873Phase 2
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresCompletedNCT00236860Phase 2
- A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.CompletedNCT00236847Phase 2
- A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut SyndromeCompletedNCT00236756Phase 3
- A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With EpilepsyCompletedNCT00236743Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control EpilepsyCompletedNCT00236730Phase 2
- A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With EpilepsyCompletedNCT00236717Phase 3
- A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCompletedNCT00236704Phase 3
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236691Phase 2
- A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential HypertensionCompletedNCT00236665Phase 3
- A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With ObesityCompletedNCT00236639Phase 3
- A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 DiabetesCompletedNCT00236626Phase 2
- A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With ObesityCompletedNCT00236613Phase 2
- A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss ProgramCompletedNCT00236600Phase 3
- A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of MigraineCompletedNCT00236561Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00236509Phase 3
- A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.CompletedNCT00236496Phase 3
- A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCompletedNCT00236418Phase 3
- A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset SeizuresCompletedNCT00233012Phase 1
- A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral PolyneuropathyCompletedNCT00231673Phase 2
- A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With MetforminCompletedNCT00231660Phase 3
- A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or MetforminCompletedNCT00231647Phase 2
- A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea TherapyTerminatedNCT00231634Phase 3
- A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With DyslipidemiaTerminatedNCT00231621Phase 3
- A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal ObesityCompletedNCT00231608Phase 2
- A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00231595Phase 3
- A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent EpilepsyCompletedNCT00231556Phase 3
- A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled DietCompletedNCT00231530Phase 3
- A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset SeizureCompletedNCT00230698Phase 3
- New Medications to Treat Alcohol DependenceCompletedNCT00223639Phase 2
- Topiramate to Reduce Cocaine DependenceCompletedNCT00223626Phase 2
- A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple SclerosisStatus unknownNCT00217295Phase 2
- The Prolonged Use of Topiramate for Preventing Migraine HeadachesCompletedNCT00216619Phase 3
- The Effectiveness and Safety of Topiramate on Prevention of Chronic MigraineCompletedNCT00216606Phase 3
- Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic EpilepsyCompletedNCT00216567Phase 4
- Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.CompletedNCT00212810Phase 4
- Topiramate Augmentation in the Treatment of Obsessive-Compulsive DisorderCompletedNCT00211744Phase 4
- An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol DependenceCompletedNCT00210925Phase 2
- A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine HeadachesCompletedNCT00210912Phase 3
- An Open Label Extension of a Study of Topiramate in Chronic Migraine.CompletedNCT00210873Phase 3
- An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.CompletedNCT00210860Phase 3
- Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine HeadachesCompletedNCT00210821Phase 3